1. Home
  2. Browse
  3. National Institutes of Health
  4. PAR-25-069

PAR-25-069National Institutes of HealthR01

Mechanisms that Impact Cancer Risk with Use of Incretin Mimetics (R01 Clinical Trial Optional)

Deadline
Award ceiling
Not stated
Awards
Not stated
Posted
Nov 18, 2024

Official announcement on the NIH Guide · opens the funder's page. Always confirm dates there.

Or read the full text and all 3 review criteria here, free with an account. Create free account

Summary

Through this notice of funding opportunity (NOFO), the National Cancer Institute (NCI) invites applications for investigator-initiated studies addressing mechanisms by which incretin mimetics, specifically glucagon-like peptide (GLP)-1 or dual GLP-1/ glucose?dependent insulinotropic polypepide (GIP)-1 receptor agonists (RAs), impact…

Related NIH announcements5

Companion announcements with the same title first, then other open R01 announcements on related subjects with at least two weeks to go.

The full announcement, free with an account

  • The full announcement text, not just the first two sentences
  • All 3 review criteria reviewers score this against, extracted from this announcement

On Plus, $39 a month

  • The eligibility check against your profile: career stage, institution type, and the windows that close before the deadline does
  • Funded precedents: what similar NIH projects received, from the award records in NIH RePORTER
  • A Reviewer Scorecard of your draft against these criteria

No card required. Browsing is free.

More from National Institutes of Health

Open now with at least two weeks to apply, soonest deadline first.

Everything open from National Institutes of Health

Related by subject

Open opportunities sharing the most subjects with this one (Cancer, Metabolic), with at least two weeks to apply.

Everything open tagged Cancer

Hiring in this research area now

All oncology jobs

Source record: https://grants.nih.gov/grants/guide/pa-files/PAR-25-069.htmlVia the NIH Guide. Last checked against the source . Always confirm dates with the funder.